Literature DB >> 2893845

The complications of 'ecstasy' (MDMA)

K Verebey, J Alrazi, J H Jaffe.   

Abstract

Mesh:

Substances:

Year:  1988        PMID: 2893845     DOI: 10.1001/jama.259.11.1649

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  8 in total

1.  Fatal poisoning by MDMA (ecstasy) and MDEA: a case report.

Authors:  V Fineschi; A Masti
Journal:  Int J Legal Med       Date:  1996       Impact factor: 2.686

2.  On acute poisoning with amphetamines.

Authors:  M J Bogusz
Journal:  Intensive Care Med       Date:  1998-02       Impact factor: 17.440

Review 3.  The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs.

Authors:  H Kalant
Journal:  CMAJ       Date:  2001-10-02       Impact factor: 8.262

4.  Non-linear pharmacokinetics of MDMA ('ecstasy') in humans.

Authors:  R de la Torre; M Farré; J Ortuño; M Mas; R Brenneisen; P N Roset; J Segura; J Camí
Journal:  Br J Clin Pharmacol       Date:  2000-02       Impact factor: 4.335

5.  Malignant hyperpyrexia in an MDMA ("Ecstasy") abuser.

Authors:  E P McCoy; C Renfrew; J R Johnston; G Lavery
Journal:  Ulster Med J       Date:  1994-04

6.  Urinary MDMA, MDA, HMMA, and HMA excretion following controlled MDMA administration to humans.

Authors:  Tsadik T Abraham; Allan J Barnes; Ross H Lowe; Erin A Kolbrich Spargo; Garry Milman; Stephane O Pirnay; David A Gorelick; Robert S Goodwin; Marilyn A Huestis
Journal:  J Anal Toxicol       Date:  2009-10       Impact factor: 3.367

7.  Plasma pharmacokinetics of 3,4-methylenedioxymethamphetamine after controlled oral administration to young adults.

Authors:  Erin A Kolbrich; Robert S Goodwin; David A Gorelick; Robert J Hayes; Elliot A Stein; Marilyn A Huestis
Journal:  Ther Drug Monit       Date:  2008-06       Impact factor: 3.681

Review 8.  Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or "Ecstasy").

Authors:  A R Green; A J Cross; G M Goodwin
Journal:  Psychopharmacology (Berl)       Date:  1995-06       Impact factor: 4.530

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.